(Q28258363)
Statements
The no-observed-adverse-effect-level in drug safety evaluations: use, issues, and definition(s) (English)
0 references
August 2005
0 references
42
0 references
3
0 references
265-74
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference